Ito K, Akamatsu N, Togashi J, Tamura S, Sakamoto Y, Hasegawa K, Kokudo N
Artificial Organ and Transplantation Surgery Division, Department of Surgery, University of Tokyo, Tokyo, Japan.
Artificial Organ and Transplantation Surgery Division, Department of Surgery, University of Tokyo, Tokyo, Japan.
Transplant Proc. 2017 Jan-Feb;49(1):109-114. doi: 10.1016/j.transproceed.2016.11.002.
The techniques and outcomes of outflow reconstruction in living donor liver transplantation (LDLT) using cryopreserved homologous veins at the University of Tokyo Hospital are presented.
We performed 540 LDLTs from January 1996 to March 2015. Graft types included right liver graft (n = 262), left liver graft (n = 196), left lateral sector graft (n = 53), and posterior sector graft (n = 28). We routinely use cryopreserved homologous vein grafts for the hepatic vein reconstructions to secure the large outflow of the graft. In addition to the presentation of our techniques, the cases with symptomatic outflow obstruction and the treatments were also investigated.
The 1-, 3-, and 5-year graft survival rates were 90.6%, 86.1%, and 83.5%, respectively. The incidence of severe complications (Clavien-Dindo grade IIIb and more) was 38%. The overall incidence of outflow obstruction requiring invasive treatment was 1.9% (10/540), including 3 left liver grafts (1.5%, 3/196) and 7 right liver grafts (2.7%, 7/262). Regarding the patency of the reconstructed veins, the left hepatic vein, middle hepatic vein, and right hepatic vein achieved nearly 100% patency. On the contrary, venous tributaries such as V5, V8, and inferior right hepatic vein were frequently occluded in the postoperative course.
Outflow reconstruction is a key for the successful LDLT. Cryopreserved homologous vein graft is useful for the promising hepatic vein reconstruction.
介绍东京大学医院在活体肝移植(LDLT)中使用冷冻保存的同种异体静脉进行流出道重建的技术及结果。
1996年1月至2015年3月期间,我们共进行了540例LDLT。移植物类型包括右肝移植物(n = 262)、左肝移植物(n = 196)、左外叶移植物(n = 53)和后叶移植物(n = 28)。我们常规使用冷冻保存的同种异体静脉移植物进行肝静脉重建,以确保移植物的大流量流出。除了介绍我们的技术外,还对有症状的流出道梗阻病例及治疗方法进行了研究。
1年、3年和5年移植物生存率分别为90.6%、86.1%和83.5%。严重并发症(Clavien-DindoⅢb级及以上)的发生率为38%。需要进行侵入性治疗的流出道梗阻的总体发生率为1.9%(10/540),其中包括3例左肝移植物(1.5%,3/196)和7例右肝移植物(2.7%,7/262)。关于重建静脉的通畅情况,左肝静脉、中肝静脉和右肝静脉的通畅率接近100%。相反,V5、V8和右下肝静脉等静脉分支在术后过程中经常闭塞。
流出道重建是LDLT成功的关键。冷冻保存的同种异体静脉移植物对有前景的肝静脉重建有用。